176 related articles for article (PubMed ID: 2181121)
21. Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics.
Munckhof WJ; Carney J; Neilson G; Neilson J; Carroll J; McWhinney B; Whitby M
Int J Antimicrob Agents; 2005 Jun; 25(6):514-22. PubMed ID: 15878264
[TBL] [Abstract][Full Text] [Related]
22. The pharmacology of clavulanic acid and ticarcillin combined.
Scully BE; Steinman R; Chin NX; Neu HC
Chemioterapia; 1984 Dec; 3(6):385-9. PubMed ID: 6529781
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of ticarcillin/clavulanate potassium in the treatment of obstetric and gynecologic infections.
Martens MG
Hosp Formul; 1990 Feb; 25(2):186-8, 192. PubMed ID: 10113105
[TBL] [Abstract][Full Text] [Related]
24. Ticarcillin/clavulanate for treatment of postpartum endometritis.
Faro S; Hammill HA; Maccato M; Martens M
Rev Infect Dis; 1991; 13 Suppl 9():S758-62. PubMed ID: 1925321
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
[TBL] [Abstract][Full Text] [Related]
27. [New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
Fujimori I
Jpn J Antibiot; 1991 Apr; 44(4):365-87. PubMed ID: 1880918
[No Abstract] [Full Text] [Related]
28. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
[TBL] [Abstract][Full Text] [Related]
29. Comparison of ticarcillin plus clavulanic acid with cefoxitin in the treatment of female pelvic infection.
Pastorek JG; Aldridge KE; Cunningham GL; Faro S; Graffeo S; McNeeley GS; Tan JS
Am J Med; 1985 Nov; 79(5B):161-3. PubMed ID: 4073084
[TBL] [Abstract][Full Text] [Related]
30. Ticarcillin plus clavulanic acid in the treatment of patients with cancer.
Fainstein V; Elting L; Pitlik S; Hortobagyi G; Keating M; Bodey GP
Am J Med; 1985 Nov; 79(5B):62-6. PubMed ID: 4073096
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains].
Shiono A; Kurihara J; Hayashi M; Suzuki T; Imai K; Yamanaka H; Takezawa Y; Kiren H; Okabe K; Tomaru Y
Hinyokika Kiyo; 1993 Aug; 39(8):777-82. PubMed ID: 8379483
[TBL] [Abstract][Full Text] [Related]
32. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
33. In vitro susceptibility of bacteria to a ticarcillin-clavulanic acid combination.
Sparks SE; Jones RL; Kilgore WR
Am J Vet Res; 1988 Dec; 49(12):2038-40. PubMed ID: 3239838
[TBL] [Abstract][Full Text] [Related]
34. Implications of beta-lactamase-inhibitor combinations.
Jones RN
J Reprod Med; 1988 Jun; 33(6 Suppl):574-8. PubMed ID: 3294402
[TBL] [Abstract][Full Text] [Related]
35. Use of ticarcillin disodium plus clavulanate potassium in the management of acute bacterial infections in children.
Gooch WM; Swenson E; Higbee MD
Am J Med; 1985 Nov; 79(5B):184-7. PubMed ID: 4073089
[TBL] [Abstract][Full Text] [Related]
36. Parenteral beta-lactamase inhibitor combinations for clinical use.
Manzella JP
Am Fam Physician; 1995 May; 51(7):1695-8. PubMed ID: 7754928
[TBL] [Abstract][Full Text] [Related]
37. Beta-lactamase inhibition: therapeutic advances. Proceedings of a symposium. Fort Lauderdale, Florida, March 22-23, 1985.
Am J Med; 1985 Nov; 79(5B):1-196. PubMed ID: 3878079
[No Abstract] [Full Text] [Related]
38. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
White AR; Stokes DH; Slocombe B; Sutherland R
J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
[TBL] [Abstract][Full Text] [Related]
39. Treatment of CAPD peritonitis with clavulanate potentiated ticarcillin.
Pasadakis P; Thodis E; Euthimiadou A; Panagoutsos S; Oustoglou E; Kartali S; Vargemezis V
Adv Perit Dial; 1992; 8():238-41. PubMed ID: 1361796
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria.
Bansal MB; Chuah SK; Thadepalli H
Am J Med; 1985 Nov; 79(5B):33-8. PubMed ID: 4073093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
